Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Behavioral Neuroscience Reports
Erschienen in: Current Behavioral Neuroscience Reports 2/2016

01.06.2016 | Geropsychiatry & Cognitive Disorders of Late Life (P Newhouse, Section Editor)

Executive Dysfunction Following Critical Illness: Exploring Risk Factors and Management Options in Geriatric Populations

verfasst von: Joanna L. Stollings, Jo Ellen Wilson, James C. Jackson, E. Wesley Ely

Erschienen in: Current Behavioral Neuroscience Reports | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Cognitive impairment is a common occurrence that has been shown to occur in over 50 % of patients following critical illness. This impairment occurs across a range of domains including attention, memory, processing speed, and executive dysfunction. In this article, we will discuss the pathophysiology behind cognitive impairment including hypoxemia and cytokines. Secondly, we will describe the risk factors for cognitive impairment including age, length of stay, and delirium. Lastly, we will review emerging data related to the use of cognitive rehabilitation, formation of postintensive care clinics in qualifying patients, and potential neuropharmacologic therapy. While our chapter focuses on cognitive impairment generally, it places a particular emphasis on executive dysfunction, not because impairment occurs solely in this domain but because impairments of an executive nature may be uniquely debilitating.
Literatur
1.
Profile of general demographic characteristics. In: US Census Bureau; 2000.
2.
Day JC. Population projections of the United States by age, sex, race, and Hispanic origin: 1993–2050. U.S. Bureau of the Census, Current Population Reports; 1993: 25–1104.
3.
Marik PE. Management of the critically ill geriatric patient. Crit Care Med. 2006;34:S176–82.CrossRefPubMed
4.
Groeger JS, Guntupalli KK, Strosberg M, Halpern N, Raphaely RC, Cerra F, et al. Descriptive analysis of critical care units in the United States: patient characteristics and intensive care unit utilization. Crit Care Med. 1993;21(2):279–91.CrossRefPubMed
5.
Hennessy D, Juzwishin K, Yergens D, Noseworthy T, Doig C. Outcomes of elderly survivors of intensive care: a review of the literature. Chest. 2005;127(5):1764–74.CrossRefPubMed
6.
Vazquez Mata G, Rivera Fernandez R, Gonzalez Carmona A, Delgado-Rodriguez M, Torres Ruiz JM, Raya Pugnaire A, et al. Factors related to quality of life 12 months after discharge from an intensive care unit. Crit Care Med. 1992;20(9):1257–62.CrossRefPubMed
7.
Montuclard L, Garrouste-Orgeas M, Timsit JF, Misset B, De Jonghe B, Carlet J. Outcome, functional autonomy, and quality of life of elderly patients with a long-term intensive care unit stay. Crit Care Med. 2000;28(10):3389–95.CrossRefPubMed
8.
Louis B, Harwood D, Hope T, Jacoby R. Can an informant questionnaire be used to predict the development of dementia in medical inpatients? Int J Geriatr Psychiatry. 1999;14(11):941–5.CrossRefPubMed
9.
Lyketsos CG, Toone L, Tschanz J, Rabins PV, Steinberg M, Onyike C, et al. Population-based study of medical comorbidity in early dementia and “cognitive impairment no dementia”: association with functional and cognitive impairment—the Cache County Study. Am J Geriatr Psychiatry. 2005;13:656–64.PubMed
10.
Royall DR, Lauterbach EC, Cummings JL, Reeve A, Rummans TA, Kaufer DI, et al. Executive control function: a review of its promise and challenges for clinical research. J Neuropsychiatry Clin Neurosci. 2002;14:377–405.CrossRefPubMed
11.
Stuss DT, Levine B. Adult clinical neuropsychology: lessons from studies of the frontal lobes. Ann Rev Psychol. 2007;53:401–33.CrossRef
12.
Burgess PW. Theory and methodology in executive function research. In: Rabbitt P, editor. Methodology of frontal and executive function. London: Oxford University Press; 1997. p. 79–108.
13.
Banich MT. Cognitive neuroscience and neuropsychology. Boston: Houghton Mifflin; 2004.
14.
Lezak MD. Neuropsychological assessment. New York: Oxford University Press; 1995.
15.
Foster JK, Black SE, Buck BH, Bronskill MJ. Methodology of frontal and executive function. In: Rabbit P, editor. Methodology of frontal and executive function. East Sussex: Psychology Press; 1997. p. 117–34.
16.
Tuokko H, Hadjistavropoulos T. An assessment guide to geriatric neuropsychology. Mahwah: Erlbaum; 1998.
17.
Ozge C, Ozge A, Unal O. Cognitive and functional deterioration in patients with severe COPD. Behav Neurol. 2006;17:121–30.CrossRefPubMed
18.
Erberk-Ozen N, Birol A, Boratav C, Kocak M. Executive dysfunction and depression in Behcet’s disease without explicit neurological involvement. Psychiatry Clin Neurosci. 2007;60:465–72.CrossRef
19.
Verdejo-Garcia A, Bechara A, Recknow EC, Perez-Garcia M. Executive dysfunction in substance dependent individual during drug use and abstinence: an examination of the behavioral, cognitive, and emotional correlates of addiction. J Int Neuropsychol Soc. 2006;12:405–15.PubMed
20.
Elderkin-Thompson V, Mintz J, Haroon E, Lavretsky H, Kumar A. Executive dysfunction and memory in older patients with major and minor depression. Arch Clin Neuropsychol. 2006;21(7):669–76.CrossRefPubMed
21.
Sherman EM, Slick DJ, Eyrl KL. Executive dysfunction is a significant predictor of poor quality of life in children with epilepsy. Epilepsia. 2006;47(11):1936–42.CrossRefPubMed
22.
Qiu WQ, Price LL, Hibberd P, Buell J, Collins L, Leins D, et al. Executive dysfunction in homebound older people with diabetes mellitus. J Am Geriatr Soc. 2006;54:496–501.CrossRefPubMed
23.
24.••
Jackson JC, Gordon SM, Ely EW, Burger C, Hopkins RO. Research issues in the evaluation of cognitive impairment in intensive care unit survivors. Intensive Care Med. 2004;30(11):2009–16. This review provides information for clinical researchers interested in the study of neuropsychological outcomes in intensive care unit survivors.CrossRefPubMed
25.
Schillerstrom JE, Horton MS, Royall DR. The impact of medical illness on executive function. Psychosomatics. 2005;46(6):508–16.CrossRefPubMed
26.
Kasper D, Brauwald E, Fauci A, Hauser S, Longo D, Jameson JL. Harrison’s principles of internal medicine. San Francisco: McGraw Hill; 2005.
27.
Schillerstrom JE, Horton MS, Schillerstorm TL, Joshi KG, Earthman BS, Velez AM, et al. Prevalence, course, and risk factors for executive impairment in patients hospitalized on a general medical service. Psychosomatics. 2007;46:411–7.CrossRef
28.••
Hopkins RO, Weaver LK, Pope D, Orme JF, Bigler ED, Larson LV. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;160(1):50–6. One year after ARDS a substantial portion of ARDS survivors exhibit impaired health status and cognitive sequelae.CrossRefPubMed
29.
Carson SS. Outcomes of prolonged mechanical ventilation. Curr Opin Crit Care. 2006;12(5):405–11.CrossRefPubMed
30.
Olson EB, Vidruk EH, McCrimmon DR, Dempsey JA. Monoamine neurotransmitter metabolism during acclimatization to hypoxia in rats. Respir Physiol. 1983;54:79–86.CrossRefPubMed
31.
Pichiule P, Chavez JC, Boero J, Arregui A. Chronic hypoxia induces modification of the N-methyl-D-aspartate receptor in rat brain. Neurosci Lett. 1996;218:83–6.CrossRefPubMed
32.
Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1982;142(8):1470–6.CrossRefPubMed
33.
Grant I, Prigatano GP, Heaton RK, McSweeny AJ, Wright EC, Adams KM. Progressive neuropsychologic impairments and hypoxemia: relationship in chronic obstructive pulmonary disease. Arch Gen Psychiatry. 1987;44:999–1006.CrossRefPubMed
34.
Verstraeten E, Cluydts R, Pevernagie D, Hoffman G. Executive function in sleep apnea: controlling for attentional capacity in assessing executive attention. Sleep. 2007;27:685–93.
35.
Verstraeten E, Dluydts R. Executive control of attention in sleep apnea patients: theoretical concepts and methodological considerations. Sleep Med Rev. 2004;8:257–67.CrossRefPubMed
36.
Semmler A, Okulla T, Sastre M, Dumitrescu-Ozimek L, Heneka MT. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat. 2007;30:144–57.CrossRef
37.
Perry VH. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun. 2004;18(5):407–13.CrossRefPubMed
38.
Wilson CJ, Finch CE, Cohen HJ. Cytokines and cognition: the case for a head to toe inflammatory paradigm. JAGS. 2002;50:2041–56.CrossRef
39.
Vitkovic L, Bockaert J, Jacque C. “Inflammatory” cytokines: neuromodulators in normal brain? J Neurochem. 2007;74:457–71.CrossRef
40.
Sparkman NL, Buchanan JB, Heyen JR, Beverly JL, Johnson RW. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J Neurosci. 2007;26:10709–16.CrossRef
41.
Mangiafico RA, Sarnataro F, Mangiafico M, Fiore CE. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels. Age Ageing. 2007;35:60–5.CrossRef
42.
Schacter J, Brenner B, Fenig E, Yahav J, Marshak G, Sulkes A, et al. Toxicity of adjuvant high-dose interferon-alpha-2b in patients with cutaneous melanoma at high risk of recurrence. Oncol Rep. 1999;6:1389–93.
43.
Pavol MA, Meyers CA, Rexer JL, Valentine AD, Mattis PJ, Talpaz M. Pattern of neurobehavioral deficits associated with interferon alpha therapy for leukemia. Neurology. 1995;45:947–50.CrossRefPubMed
44.
Poutiainen E, Hokkanen L, Niemi ML, Farkilla M. Reversible cognitive decline during high-dose alpha-interferon treatment. Pharmacol Biochem Behav. 1994;47:901–5.CrossRefPubMed
45.••
Jones C, Griffiths RD, Slater T, Benjamin KS, Wilson S. Significant cognitive dysfunction in non-delirious patients identified during and persisting following critical illness. Intensive Care Med. 2006;32(6):923–6. Difficulties with problem solving and poor memory can remain a significant issue for months after ICU discharge.CrossRefPubMed
46.
Voytko ML. Impairments in acquisition and reversals of two-choice discriminations by aged rhesus monkeys. Neurobiol Aging. 1999;20:617–27.CrossRefPubMed
47.
Boone KB, Ghaffarian S, Lesser IM, Hill-Gutierrez E, Berman NG. Wisconsin Card Sorting Test performance in healthy, older adults: relationship to age, sex, education, and IQ. J Clin Psychol. 1993;49(1):54–60.CrossRefPubMed
48.
Haaland KY, Vranes LF, Goodwin JS, Garry PJ. Wisconsin Card Sort Test performance in a healthy elderly population. J Gerontol. 1987;42(3):345–6.CrossRefPubMed
49.
Gunning-Dixon FM, Raz N. Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study. Neuropsychologia. 2003;41(14):1929–41.CrossRefPubMed
50.
Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry. 2000;5:132–48.PubMed
51.
Fong TG, Bogardus ST, Daftary A, Auerbach E, Blumenfeld H, Modur S, et al. Cerebral perfusion changes in older delirious patients using 99mTc HMPAO SPECT. J Gerontol Med Sci. 2007;61A:1294–9.
52.
Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. Am J Neuroradiol. 2007;11:431.
53.
Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357–81.CrossRefPubMed
54.
Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126–34.CrossRefPubMed
55.
Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38(7):1513–20.CrossRefPubMedPubMedCentral
56.••
Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306–16. Patients in medical and surgical ICUs are at high risk for long-term cognitive impairment. At 3 and 12 months, a longer duration of delirium in the hospital was associated with worse global cognition and executive function scores.CrossRefPubMedPubMedCentral
57.
Kiosses DN, Alexopoulos GS. IADL functions, cognitive deficits, and severity of depression: a preliminary study. Am J Geriatr Psychiatry. 2005;13(3):244–9.CrossRefPubMed
58.
Jefferson AL, Paul RH, Ozonoff A, Cohen RA. Evaluating elements of executive functioning as predictors of instrumental activities of daily living (IADLs). Arch Clin Neuropsychol. 2006;21(4):311–20.CrossRefPubMedPubMedCentral
59.
Cahn-Weiner DA, Boyle PA, Malloy PF. Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Appl Neuropsychol. 2002;9(3):187–91.CrossRefPubMed
60.
Boyle PA, Cohen RA, Moser D, Gordon N. Cognitive and motor impairments predict functional declines in patients with vascular dementia. Int J Geriatr Psychiatry. 2002;17:164–9.CrossRefPubMed
61.
Boyle PA, Paul RH, Moser DJ, Cohen RA. Executive impairments predict functional declines in vascular dementia. Clin Neuropsychol. 2004;18(1):75–82.CrossRefPubMed
62.
Boyle PA, Malloy PF, Salloway S, Cahn-Weiner DA, Cohen R, Cummings JL. Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry. 2007;11:214–21.CrossRef
63.
Royall DR, Cabello M, Polk MJ. Executive dyscontrol: an important factor affecting the level of care received by older retirees. J Am Geriatr Soc. 1998;46:19–24.CrossRef
64.
Royall DR, Chiodo LK, Polk MJ. Correlates of disability among elderly retirees with “subclinical” cognitive impairment. J Gerontol Ser A Biol Med Sci. 2007;55:M541–6.CrossRef
65.
Burton CL, Strauss E, Hultsch DF, Hunter MA. Cognitive functioning and everyday problem solving in older adults. Clin Neuropsychol. 2006;20(3):432–52.CrossRefPubMed
66.
Spinella M, Yang B, Lester D. Prefrontal system dysfunction and credit card debt. Int J Neurosci. 2004;114:1323–32.CrossRefPubMed
67.
Van Vielingen TE, Tuokko HA, Cramer K, Mateer CA, Hultsch DF. Awareness of financial skills in dementia. Aging Ment Health. 2004;8:374–80.CrossRef
68.
Insel K, Morrow D, Brewer B, Figueredo A. Executive function, working memory, and medication adherence among older adults. J Gerontol B Psychol. 2006;61(2):P102–7.CrossRef
69.
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2007;10:317–31.
70.
Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, et al. Medication adherence among HIV+ adults—effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59(12):1944–50.CrossRefPubMedPubMedCentral
71.
Stewart JT, Gonzalez-Perez E, Zhu Y, Robinson BE. Cognitive predictors of resistiveness in dementia patients. Am J Geriatr Psychiatry. 1999;7(3):259–63.CrossRefPubMed
72.
Allen SC, Jain M, Ragab S, Malik N. Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects. Age Ageing. 2003;32(3):299–302.CrossRefPubMed
73.
Kalhan R, Mikkelsen M, Dedhiya P, Christie J, Gaughan C, Lanken PN, et al. Underuse of lung protective ventilation: analysis of potential factors to explain physician behavior. Crit Care Med. 2006;34(2):300–6.CrossRefPubMed
74.
Biederman J, Petty C, Fried R, Fontanella J, Doyle AE, Seidman LJ, et al. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 2006;163(10):1730–8.CrossRefPubMed
75.
Evans JD, Bond GR, Meyer PS, Kim HW, Lysaker PH, Gibson PJ, et al. Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia. Schizophr Res. 2004;70:331–42.CrossRefPubMed
76.
McGurk SR, Mueser KT. Cognitive and clinical predictors of work outcomes in clients with schizophrenia receiving supported employment services: 4-year follow-up. Adm Policy Ment Health. 2006;33:598–606.CrossRefPubMed
77.
Washburn AM, Sands LP. Social cognition in nursing home residents with and without cognitive impairment. J Gerontol B Psychol Sci Soc Sci. 2006;61:174–9.CrossRef
78.
Liddle PF. Cognitive impairment in schizophrenia: its impact on social functioning. Acta Psychiatr Scand Suppl. 2000;400:11–6.CrossRefPubMed
79.
Greenwood KE, Landau S, Wykes T. Negative symptoms and specific cognitive impairments as combined target for improved functional outcome within cognitive remediation therapy. Schizophr Bull. 2005;31:910–21.CrossRefPubMed
80.
King KE, Arnett PA. Predictors of dyadic adjustment in multiple sclerosis. Mult Scler. 2005;11(6):700–7.CrossRefPubMed
81.
Pinkston JB, Alekseeva N. Neuropsychiatric manifestations of multiple sclerosis. Neurol Res. 2006;28:284–90.CrossRefPubMed
82.
Ribi K, Relly C, Landolt MA, Alber FD, Boltshauser E, Grotzer MA. Outcome of medulloblastoma in children: long-term complications and quality of life. Neuropediatrics. 2005;36:357–65.CrossRefPubMed
83.
Aksaray G, Oflu S, Kaptanoglu C, Bal C. Neurocognitive deficits and quality of life in outpatients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:1217–9.CrossRefPubMed
84.
Osowiecki DM, Cohen RA, Morrow KM, Paul RH, Carpenter CC, Flanigan T, et al. Neurocognitive and psychological contributions to quality of life in HIV-1-infected women. AIDS. 2000;14:1327–32.CrossRefPubMed
85.
Brummel NE, Girard TD, Ely EW, Pandharipande PP, Morandi A, Hughes CG, et al. Feasibility and safety of early combined cognitive and physical therapy for critically ill medical and surgical patients: the Activity and Cognitive Therapy in ICU (ACT-ICU) trial. Intensive Care Med. 2014;40(3):370–9.CrossRefPubMedPubMedCentral
86.
Jackson JC, Ely EW, Morey MC, Anderson VM, Denne LB, Clune J, et al. Cognitive and physical rehabilitation of intensive care unit survivors: results of the RETURN randomized controlled pilot investigation. Crit Care Med. 2012;40(4):1088–97.CrossRefPubMedPubMedCentral
87.
Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C, Wunsch H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference*. Crit Care Med. 2012;40(2):502–9.CrossRefPubMed
88.
Bell CM, Brener SS, Gunraj N, Huo C, Bierman AS, Scales DC, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA. 2011;306(8):840–7.CrossRefPubMed
89.
Griffiths JA, Barber VS, Cuthbertson BH, Young JD. A national survey of intensive care follow-up clinics. Anaesthesia. 2006;61(10):950–5.CrossRefPubMed
90.
Daffurn K, Bishop GF, Hillman KM, Bauman A. Problems following discharge after intensive care. Intensive Crit Care Nurs. 1994;10(4):244–51.CrossRefPubMed
91.
Wergin R, Modrykamien A. Cognitive impairment in ICU survivors: assessment and therapy. Cleve Clin J Med. 2012;79(10):705–12.CrossRefPubMed
92.
Allain H, Bentue-Ferrer D, Akwa Y. Treatment of the mild cognitive impairment (MCI). Hum Psychopharmacol. 2007;22(4):189–97.CrossRefPubMed
93.
Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neuro-Oncol. 2012;107(1):165–74.CrossRef
94.
Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, et al. Survivorship: cognitive function, version 1.2014. J Natl Compr Canc Netw. 2014;12(7):976–86.PubMedPubMedCentral
Metadaten
Titel
Executive Dysfunction Following Critical Illness: Exploring Risk Factors and Management Options in Geriatric Populations
verfasst von
Joanna L. Stollings
Jo Ellen Wilson
James C. Jackson
E. Wesley Ely
Publikationsdatum
01.06.2016
Verlag
Springer International Publishing
Erschienen in
Current Behavioral Neuroscience Reports / Ausgabe 2/2016
Elektronische ISSN: 2196-2979
DOI
https://doi.org/10.1007/s40473-016-0076-3

Weitere Artikel der Ausgabe 2/2016

Current Behavioral Neuroscience Reports 2/2016 Zur Ausgabe

Neuromodulation (S Taylor, Section Editor)

Enhancing Cognition with Theta Burst Stimulation

Mood and Anxiety Disorders (D Iosifescu, Section Editor)

Current Trends in Identifying Rapidly Acting Treatments for Depression

Psychosis (A Ahmed, Section Editor)

The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia

Psychosis (A Ahmed, Section Editor)

Can Oxytocin Enhance Social Affiliation in Schizophrenia?

Neuromodulation (S Taylor, Section Editor)

Current Status of Transcranial Direct Current Stimulation in Posttraumatic Stress and Other Anxiety Disorders

Neuromodulation (S Taylor, Section Editor)

Advances in the Application of Electroconvulsive Therapy

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise